StockData
QIAGEN N.V. logo

QIAGEN N.V. (QGEN) stock

QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 10/30
$49.75−0.06 (-0.12%)

Close on Nov 17, 2026Market cap $10.79BP/E 25.6Yield 0.50%

Qiagen profit margin

Profit margin (net margin) is net income as a percentage of revenue.

For fiscal 2025 it was 20.3%, against 4.2% the year before. The highest annual figure on record is 22.8% in fiscal 2021.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202520.3%+16.1
FY2024Dec 31, 20244.2%−13.1
FY2023Dec 31, 202317.4%−2.4
FY2022Dec 31, 202219.8%−3.0
FY2021Dec 31, 202122.8%+3.6
FY2020Dec 31, 202019.2%+21.9
FY2019Dec 31, 2019-2.7%−15.4
FY2018Dec 31, 201812.7%+9.8
FY2017Dec 31, 20172.8%−3.2
FY2016Dec 31, 20166.0%−4.2
FY2015Dec 31, 201510.2%+1.5
FY2014Dec 31, 20148.7%+3.3
FY2013Dec 31, 20135.3%−5.0
FY2012Dec 31, 201210.3%+2.1
FY2011Dec 31, 20118.2%−5.1
FY2010Dec 31, 201013.3%−0.4
FY2009Dec 31, 200913.6%+3.7
FY2008Dec 31, 200810.0%–

More Qiagen figures

See a number that looks wrong?